Category: Biomarkers
Biomarker-Driven Research: Transforming Treatments for Rare Cancers Reassessing the classification of rare cancer types Historically, research on rare cancers centered around tumor Read Now
Reflections from ESMO 2025 Progress, Breakthrough Science and the Future of Oncology We were delighted to attend the recent Read Now
The Resurgence of Antibody-drug Conjugates How ADCs are redefining cancer therapy Cancer treatment is undergoing a transformation, fueled by advances Read Now
Advancing Lung Cancer Trials with Precision Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related deaths Read Now
Key Takeaways from World ADC 2024 The resurgence of ADCs in cancer therapy The World ADC conference is the leading conference Read Now
Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now